CODX vs SPGI
Co-Diagnostics, Inc. Common Stock (CODX) versus S&P Global Inc (SPGI) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
S&P Global Inc (SPGI) is a financial data & stock exchanges company listed on NYSE.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported SPGI revenue for 2025-12-31 was $15.34B. Net income was $4.47B. Revenue was up 7.9% from 2024-12-31 to 2025-12-31. SPGI currently screens at market cap $127.50B and trailing P/E 27.2.
CODX currently screens at market cap $31.4M. SPGI currently screens at market cap $127.50B and trailing P/E 27.2.
Not investment advice. Open the CODX and SPGI stock pages for the full models.
Not investment advice.